Regenerative Treatments
for Ophthalmic Diseases

Neuroptika’s mission is to improve patients’ lives by developing novel regenerative therapies for ophthalmic diseases

 

PIPELINE

NRO-1

Neurotrophic Keratitis

NRO-CMK

Nerve degeneration prevention gene therapy

NRO-VTN

Novel geographic atrophy target

PHASE 1

PRECLINICAL

PHASE 2

UNDER CONSTRUCTION

Detailed program descriptions to follow